Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network.

Exploratory cox analyses in the pre-PSM cohort of 1-year mortality In an exploratory multivariable Cox regression analysis of 1-year mortality conducted in the overall (pre-matched) cohort ( Supplementary Table 5 ), treatment with Atezo+Bev was associated with a numerically lower hazard of death compared with Treme+Dur (HR, 0.865; 95% CI, 0.733–1.021; p = 0.087); however, this difference did not reach statistical significance.

also in 111,027 other papers